Signalomics

Signalomics is a precision medicine company focused on mapping the "signalome"—the complex network of signaling pathways within cells—to improve cancer diagnosis and treatment. Utilizing advanced proteomics and proprietary bioinformatics, the company identifies specific signaling aberrations that drive tumor growth and drug resistance in individual patients. This functional approach allows Signalomics to predict drug sensitivity more accurately than traditional genomic sequencing alone. The company's platform supports both the discovery of novel therapeutic targets and the development of companion diagnostics for personalized oncology care. By capturing the dynamic state of protein interactions, Signalomics aims to provide a more comprehensive understanding of disease biology than static DNA-based methods.